<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are characterised by dysplastic marrow and cytopenia </plain></SENT>
<SENT sid="1" pm="."><plain>Clinically detectable <z:mp ids='MP_0001914'>bleeding</z:mp> is uncommon and usually attributed to <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We have investigated some aspects of haemostatic function in 17 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and compared the results with findings from 17 control patients matched for age and sex </plain></SENT>
<SENT sid="3" pm="."><plain>No specific disorder of blood coagulation or fibrinolysis was identified </plain></SENT>
<SENT sid="4" pm="."><plain>The main abnormalities observed in the patients were: prolongation of the <z:mp ids='MP_0001914'>bleeding</z:mp> time which was greater than could be explained on the basis of <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> in 13 patients; absent, or severely <z:hpo ids='HP_0003540'>impaired platelet aggregation</z:hpo> in response to collagen in 7 patients; impaired platelet production of malondialydehyde when stimulated with collagen and abnormal release of <z:chebi fb="32" ids="36927">14C</z:chebi>-5 hydroxytryptamine in 5 patients; and abnormalities of ultrastructure in <z:hpo ids='HP_0000001'>all</z:hpo> 5 patients whose platelets were viewed by electron microscopy </plain></SENT>
</text></document>